GS-5806 Inhibits Pre- to Postfusion Conformational Changes of the Respiratory Syncytial Virus Fusion Protein

ABSTRACT GS-5806 is a small-molecule inhibitor of human respiratory syncytial virus fusion protein-mediated viral entry. During viral entry, the fusion protein undergoes major conformational changes, resulting in fusion of the viral envelope with the host cell membrane. This process is reproduced in vitro using a purified, truncated respiratory syncytial virus (RSV) fusion protein. GS-5806 blocked these conformational changes, suggesting a possible mechanism for antiviral activity.

[1]  M. Desai,et al.  Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study. , 2015, Journal of medicinal chemistry.

[2]  M. Luo,et al.  Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors , 2014, Proceedings of the National Academy of Sciences.

[3]  D. Hui,et al.  High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  K. Poehling,et al.  Respiratory Syncytial Virus–Associated Hospitalizations Among Children Less Than 24 Months of Age , 2013, Pediatrics.

[5]  K. Edwards,et al.  Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. , 2012, The Journal of infectious diseases.

[6]  A. Curns,et al.  Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006 , 2012, The Pediatric infectious disease journal.

[7]  R. Epand,et al.  Soluble Respiratory Syncytial Virus Fusion Protein in the Fully Cleaved, Pretriggered State Is Triggered by Exposure to Low-Molarity Buffer , 2011, Journal of Virology.

[8]  S. Madhi,et al.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis , 2010, The Lancet.

[9]  H. V. van Vlijmen,et al.  Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein , 2009, Proceedings of the National Academy of Sciences.

[10]  K. Poehling,et al.  The burden of respiratory syncytial virus infection in young children. , 2009, The New England journal of medicine.

[11]  D. Roymans,et al.  Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection. , 2009, Current opinion in drug discovery & development.

[12]  E. Walsh,et al.  Respiratory syncytial virus infection in elderly and high-risk adults. , 2005, The New England journal of medicine.

[13]  N. Meanwell,et al.  Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Romero.  Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage , 2003, The Pediatric infectious disease journal.

[15]  B. Mellen,et al.  Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. , 2000, The Journal of pediatrics.

[16]  J. McKimm-Breschkin.  VP-14637 ViroPharma. , 2000, Current opinion in investigational drugs.

[17]  R. Holman,et al.  Bronchiolitis-associated hospitalizations among US children, 1980-1996. , 1999, JAMA.

[18]  N. Meanwell,et al.  pH-Dependent Changes in Photoaffinity Labeling Patterns of the H1 Influenza Virus Hemagglutinin by Using an Inhibitor of Viral Fusion , 1999, Journal of Virology.

[19]  R. Hodges,et al.  Salt effects on protein stability: two-stranded alpha-helical coiled-coils containing inter- or intrahelical ion pairs. , 1997, Journal of molecular biology.

[20]  R. M. Iorio,et al.  Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. , 1995, Virology.

[21]  R. Ray,et al.  Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses , 1992, Journal of virology.

[22]  K. Dimock,et al.  The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. , 1991, Virology.

[23]  R. Karron,et al.  Respiratory syncytial virus and metapneumovirus , 2007 .